Picture of Braxia Scientific logo

BRAX Braxia Scientific Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m+1.82%
3m+2.34%
6m-0.59%
1yr-70.36%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-7248.88%
Return on Equity-254.58%
Operating Margin-442.97%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Braxia Scientific EPS forecast chart

Profile Summary

Braxia Scientific Corp. is a Canada-based medical research and telemedicine company with a clinic that provide ketamine treatments for persons with depression and related disorders. Through its medical solutions, it intends to reduce the illness burden of brain-based disorders, such as major depressive disorder, among others. The Company is primarily focused on owning and operating multidisciplinary clinics, providing treatment for mental health disorders, and research activities related to discovering and commercializing novel drugs and delivery methods. It seeks to develop ketamine and derivatives and other psychedelic products from its IP development platform. The Company has clinic operations in the Canadian cities of Mississauga, Kitchener-Waterloo, Ottawa and Montreal. Its subsidiary, Braxia Health, is engaged in offering rapid onset treatments to aid those suffering from several treatment-resistant conditions, such as depression and bipolar disorder.

Directors

    Last Annual
    March 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    March 26th, 2019
    Public Since
    February 27th, 2020
    Sector
    Healthcare Providers & Services
    Industry
    Healthcare
    Exchange
    ca flag iconCanadian Securities Exchange
    Shares in Issue
    263,708,939

    BRAX Share Price Performance

    Upcoming Events for BRAX

    Braxia Scientific Corp Annual Shareholders Meeting

    Similar to BRAX

    Picture of 4Front Ventures logo

    4Front Ventures

    ca flag iconCanadian Securities Exchange

    Picture of Ascend Wellness Holdings logo

    Ascend Wellness Holdings

    ca flag iconCanadian Securities Exchange

    Picture of Ayr Wellness logo

    Ayr Wellness

    ca flag iconCanadian Securities Exchange

    Picture of Craftport Cannabis logo

    Craftport Cannabis

    ca flag iconCanadian Securities Exchange

    Picture of Fluent logo

    Fluent

    ca flag iconCanadian Securities Exchange

    FAQ